Medicared For All Logo

Ajithkumar Puthillath in Stockton, California

Home California Stockton

Ajithkumar Puthillath has Medical Oncology as his primary medical specialty. Their primary office is: 2626 N California St in Stockton, California.

They're a part of the: Stockton Hematology Oncology Medical Group Inc medical group which has around 8 members. You can call their office at 209-466-2626 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2001 (around 23 years of experience). They are listed as doing telehealth appointments.


Ajithkumar Puthillath Office Phone and Directions

Ajithkumar Puthillath
Stockton Hematology Oncology Medical Group Inc
2626 N California St
Stockton, California 95204
209-466-2626


Patient Ratings
Please rate your experience with Ajithkumar Puthillath below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 209-466-2626


Enter a starting address:


Healthcare Info for Ajithkumar Puthillath

Medical School: Sorry, his university is not listed
Graduation Year: 2001
The Primary Medical Specialty for Ajithkumar Puthillath is listed as: Medical Oncology
Approximate Years of Experience: 23
PAC (PECOS ID)#: 7810033925
NPI #: 1225275233
NPI Created On: 01/13/2009
NPI Last Updated Listed as: 07/31/2014
Primary Taxonomy Code: 174400000X
License Number:
A107213
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Nuclear medicine study with ct imaging skull base to mid-thigh
  3. Complete blood cell count (red cells, white blood cell, platelets), automated test
  4. Hydration infusion into a vein 31 minutes to 1 hour
  5. Hydration infusion into a vein
  6. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  7. Infusion into a vein for therapy, prevention, or diagnosis
  8. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  9. Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion
  10. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  11. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  12. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  13. Infusion of different chemotherapy drug or substance into a vein
  14. Infusion of chemotherapy into a vein up to 1 hour
  15. Infusion of chemotherapy into a vein
  16. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  17. Irrigation of implanted venous access drug delivery device
  18. New patient office or other outpatient visit, typically 45 minutes
  19. New patient office or other outpatient visit, typically 60 minutes
  20. Established patient office or other outpatient visit, typically 15 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788010107

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: ERLEADA

Associated Drug #2: 59676-600-12

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: BALVERSA

Name Of Drug #3: 59676-030-56

Drug or Biological: Biological

Product Category #4: Oncology

Name of Drug #4: DARZALEX

Associated Drug #4: 57894-502-05


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788010109

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781462629

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CINV

Name of Drug #1: Cinvanti

Open Associated Drug #1: 47426-201-01


Payments Total: $30

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545279

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545281

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545283

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832163165

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832163373

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01


Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783687653

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Hematology

Name of Drug #1: REBLOZYL

Open Associated Drug #1: 59572-711-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783474507

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Medical Oncology Professionals in Stockton

7373 W Lane
Stockton, CA
Permanente Medical Group Inc

7373 W Lane
Stockton, CA
Permanente Medical Group Inc

Providers in Stockton Hematology Oncology Medical Group Inc

1.Neelesh Bangalore Md

2626 N California St
Stockton Ca 95204-5500
Stockton Hematology Oncology Medical Group Inc
Hematology

2.Neelesh Bangalore Md

801 S Ham Ln
Lodi Ca 95242-7503
Stockton Hematology Oncology Medical Group Inc
Hematology

3.Neelesh Bangalore Md

300 Northgate Dr
Manteca Ca 95336-3139
Stockton Hematology Oncology Medical Group Inc
Hematology

4.Neelesh Bangalore Md

1325 Melrose Ave
Modesto Ca 95350-5581
Stockton Hematology Oncology Medical Group Inc
Hematology

5.Neelesh Bangalore Md

2316 Orchard Pkwy
Tracy Ca 95377-7324
Stockton Hematology Oncology Medical Group Inc
Hematology

6.Mussa Banisadre

2626 N California St
Stockton Ca 95204-5500
Stockton Hematology Oncology Medical Group Inc
Hematology

View all 8 members of Stockton Hematology Oncology Medical Group Inc medical group